BIDMC's Marc Schermerhorn, MD, Chief of the Division of Vascular and Endovascular Surgery, is available for interview to discuss why he feels strongly the AAA screening recommendations should be expanded to include other groups.
New research led by Queen’s University Belfast has found that men who are on statins, medicine used to lower blood cholesterol, may have a reduced risk of developing a more lethal form of prostate cancer.
A recent study published in Muscle & Nerve explored the prevalence of male sexual dysfunction in type 1 diabetes. Written by Ana Calzada-Reyes of Havana, Cuba, the study investigated the “prevalence of sexual dysfunction in a sample of males with type 1 diabetes.”
A new study by Vanderbilt-Ingram Cancer Center (VICC) researchers published in Clinical Cancer Research, a journal of the American Association for Cancer Research, indicates that a lower threshold is needed for male patients to predict mortality using the genetic assay, Oncotype DX®, a commercial diagnostic test. The study’s lead author is Fei Wang, MD, PhD, a visiting research fellow at Vanderbilt University, and its senior author is Xiao-Ou Shu, MD, PhD, MPH, Ingram Professor of Cancer Research and associate director for Global Health and co-leader of the Cancer Epidemiology Research Program at VICC.
Research from Florida State University is giving physicians a better understanding of ketamine, a potentially useful tool in treating depression that still has unanswered questions. A team of researchers working in the laboratory of Mohamed Kabbaj, a professor of Biomedical Sciences and Neuroscience in the College of Medicine, showed that ketamine can decrease alcohol consumption in male rats that previously had consumed high amounts of alcohol when given unrestricted access several times a week.
More than $2.3 million in Research Scholar Grants from the American Cancer Society have been awarded to three Rutgers Cancer Institute of New Jersey researchers to examine cell metabolism and tumor formation in forms of breast cancer, lung cancer and leukemia.
Newly diagnosed prostate cancer patients have multiple standard-of-care treatment options available, but many are not fully informed of their choices. A study led by researchers at The University of Texas MD Anderson Cancer Center found men who seek treatment at a multidisciplinary (MultiD) prostate cancer clinic are more likely to be advised about treatment choices and to receive care that complies with evidence-based treatment guidelines.
It's Lung Cancer Awareness Month and there are few stories about women who are diagnosed with lung cancer. Here’s one story about a 42-year-old, non-smoking Mom of two who was surprised with a lung cancer diagnosis last Thanksgiving. The story also features tips from a UCLA pulmonologist on the signs and symptoms of lung cancer.
Un estudio de Mayo Clinic publicado en American Journal of Health Behavior investiga las diferencias entre hombres y mujeres en cuanto a la percepción de su propia salud. El estudio descubrió que el sexo de la persona influye sobre la seguridad de poder mantener buenos hábitos de salud.
The success of antiretroviral therapies has extended the lives of people living with HIV, long enough for other chronic health conditions to emerge, including a recently documented uptick in sudden death.
Strong same-sex friendships among male firefighters can help cut down on their stress — but loving relationships with their wives may increase anxiety for those who constantly face danger, according to a Baylor University study.
A Mayo Clinic study published in the American Journal of Health Behavior investigates differences in how men and women perceive their own health. The study finds that confidence in maintaining good health habits can be influenced by gender.
An unexpected discovery about fertilization reveals new insights on how sperm and egg fuse and could have major implications for couples battling infertility – and may lead to a future male contraceptive.
Researchers at Hospital for Special Surgery (HSS) in New York City launched a nationwide survey to assess the needs of male patients and found that 58% reported feeling depressed for several days or more than half the days in the previous two weeks.
Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.
Roland Taylor, 69, has faced considerable struggles in life, at times battling homelessness and addiction. Two years ago, he felt a lump in his chest, but ignored it until he discovered that it had grown. He went to the doctor and was shocked to learn that he had breast cancer.
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
A Keck School of Medicine of USC study compared the Pinktober and Movember movements, showing that reach and engagement do not always lead people to research screening options
Highlights
• Rates for all types of kidney replacement therapy in European countries were consistently higher in men than women from 1965 to 2015.
• Male-to-female ratios increased with age, showing consistency over decades and for individual countries, despite changes in the causes of kidney disease.
• The male-to-female ratio was higher for kidney transplantation in diabetic patients.
A Cooperative Research Center (CRC) has been established by the National Institutes of Health at three institutions including the Lawrence Livermore National Laboratory (LLNL), the University of California, Irvine (UCI) and the University of California, Davis, with a single goal to enhance and accelerate the development of vaccines for Chlamydia trachomatis genital infections.
Routine use of opioids after vasectomy doesn't improve pain control, but is associated with a substantial rate of persistent opioid use in the months after the procedure, reports a study in the October issue of The Journal of Urology®, Official Journal of the American Urological Association (AUA). The Journal is published in the Lippincott portfolio by Wolters Kluwer.
Researchers from the UCLA Jonsson Comprehensive Cancer Center and other institutions in the U.S., Canada, the United Kingdom and Singapore, have identified 1,178 biomarkers in men’s genomes — the complete set of genetic material inherited from one’s parents — that predict how an individual person’s prostate cancer will grow.
The finding suggests that predicting how a person’s cancer will evolve may lie in their inherited DNA.
Results from the first long-term cohort study of more than 36,000 Japanese men over decades suggest an association between eating mushrooms and a lower risk of prostate cancer.
As Breast Cancer Awareness Month kicks off this October, a UNLV public health professor is reminding people that men are also at risk. Statistics show that about 1 in 8 U.S. women will develop invasive breast cancer over the course of her lifetime, leading to it be seen primarily as a “woman’s disease.” But that view unintentionally creates a health disparity for men, who — with a lifetime risk of developing breast cancer sitting at about 1 in 883 — often face barriers to diagnosis and treatment due to a lack of awareness among the general public, policymakers, and health care professionals, says Marya Shegog, director of health programs at The Lincy Institute at UNLV.
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient’s post-operative prostate-specific antigen (PSA) level. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
PTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function. These findings were published by George Washington University Cancer Center researchers in Nature Communications.
Loyola Medicine is among the first centers to offer a new minimally invasive prostate cancer biopsy that minimizes the risk of infection and may increase the cancer detection rate. It's called the transperineal prostate biopsy.
Atlantic Health System Cancer Care at Overlook Medical Center is now offering a highly advanced technology that will enhance the ability of physicians to diagnose, stage and treat prostate cancer. The UroNav Fusion Biopsy System fuses pre-biopsy magnetic resonance imaging (MRI) images of the prostate with ultrasound-guided 3-D images in real time, allowing for excellent imaging of the prostate and any abnormal changes (lesions) that may or may not be cancerous.
Michigan's two comprehensive cancer center, the University of Michigan Rogel Cancer and the Barbara Ann Karmanos Cancer Institute, have received a prestigious $9.2 million grant from the National Cancer Institute for prostate cancer research.
UC San Francisco announced Thursday it will establish the UCSF Benioff Initiative for Prostate Cancer Research, made possible by a $35 million gift from Marc and Lynne Benioff.
Blocking a kinase known as CDK7 sets off a chain reaction that results in the death of prostate cancer cells that have spread and are resistant to standard therapies
Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate.
Former NFL players reporting concussion symptoms following head injury more likely to report erectile dysfunction and low testosterone levels
Players reporting the most concussion symptoms have nearly twice the risk of ED, compared with players with the fewest symptoms
The elevated risk was present even when researchers accounted for other possible drivers of ED as well as among younger players who suffered concussions
Researchers caution that the exact biological mechanisms remain to be elucidated, but injury to the pituitary gland and downstream hormonal changes may be one possible explanation
Players with ED should seek prompt evaluation for this common, highly treatable condition, which can also indicate the presence of other diseases, including cardiovascular illness and diabetes
Clinicians treating patients with head trauma should inquire proactively about symptoms of ED and low testosterone
Results may be relevant in other sports where head injuries are common, including h
With National Prostate Health Month quickly approaching in September, the Prostate Cancer Program at the Cancer Center at Beth Israel Deaconess Medical Center has several expert sources that may be helpful for stories you are working on now or in the future.
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.
A Rensselaer researcher recently received the latest in a series of grants aimed at advancing current imaging technology, and developing new tools for diagnosis and treatment delivery. The most recent award, from the National Institute of Biomedical Imaging and Bioengineering, will help him improve an image fusion technique — currently used clinically to enable biopsies for diagnosis — without external tracking devices.
On August 4, a special session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo will shed much-needed light on the nuances of direct-to-consumer genetic testing.
Researchers from the UCLA Jonsson Comprehensive Cancer Center undertook a head-to-head comparison of two imaging techniques and have concluded that prostate-specific membrane antigen imaging is more effective in detecting the location of the prostate cancer recurrence.
Discovery shows how difficult-to-treat prostate cancer evades immune system and reports pre-clinical development of novel treatment and potential for combination use with immunotherapy drugs.